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Ostreolysin, a cytolytic protein from the edible oyster mushroom (Pleurotus ostreatus), recognizes and binds specifically to membrane domains
enriched in cholesterol and sphingomyelin (or saturated phosphatidylcholine). These events, leading to permeabilization of themembrane, suggest that a
cholesterol-rich liquid-orderedmembrane phase, which is characteristic of lipid rafts, could be its possible binding site. In thiswork,we present effects of
ostreolysin on membranes containing various steroids. Binding andmembrane permeabilizing activity of ostreolysin was studied using lipid mono- and
bilayers composed of sphingomyelin combined, in a 1/1 molar ratio, with natural and synthetic steroids (cholesterol, ergosterol, β-sitosterol,
stigmasterol, lanosterol, 7-dehydrocholesterol, cholesteryl acetate, and 5-cholesten-3-one). Binding to membranes and lytic activity of the protein are
both shown to be dependent on the intact sterol 3β-OH group, and are decreased by introducing additional double bonds and methylation of the steroid
skeleton or C17-isooctyl chain. The activity of ostreolysin mainly correlates with the ability of the steroids to promote formation of liquid-ordered
membrane domains, and is the highest with cholesterol-containing membranes. Furthermore, increasing the cholesterol concentration enhanced
ostreolysin binding in a highly cooperative manner, suggesting that the membrane lateral distribution and accessibility of the sterols are crucial for the
activity of this new member of cholesterol-dependent cytolysins.
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Sterols are essential components of eukaryotic membranes,
which enable the cells to modulate and optimise certain physical
properties of the membrane that relate to their biological function.
This is connected especially with their ability to promoteAbbreviations: 7-DHC, 7-dehydrocholesterol; CDC, cholesterol-dependent
cytolysin; Ch-Ac, cholesteryl acetate; Chol, cholesterol; Ch-one, 5-cholesten-3-
one; DOPC, dioleoylphosphatidylcholine; DPH, 1,6-diphenyl-1,3,5-hexatriene;
DPPC, dipalmitoylphosphatidylcholine; DRM, detergent-resistant membrane;
DSC, differential scanning calorimetry; EDTA, ethylenediaminetetraacetic acid;
Ergo, ergosterol; Lano, lanosterol; ld, liquid disordered domain; lo, lipid ordered
domain; MLV, multilamellar vesicles; PC, phosphatidylcholine; POPC,
palmitoyloleoylphosphatidylcholine; RU, resonance unit; Sito, β-sitosterol;
SPR, surface plasmon resonance; Stig, stigmasterol; SV, sonicated vesicles; Oly,
ostreolysin; SM, sphingomyelin; TRIS, (hydroxymethyl)aminomethane; VCC,
Vibrio cholerae cytolysin
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doi:10.1016/j.bbamem.2006.06.003separation of lipid mixtures into co-existing liquid-disordered
(ld) and liquid-ordered (lo) phases [1]. The lo membrane domains
emerge as a result of a local enrichment in sterols, and are the basis
for the formation of lipid rafts, transient membranemicrodomains
enriched in sterols and sphingolipids [2]. These membrane en-
tities had been reported to be involved in a variety of biological
functions, such as membrane traffic, signal transduction and
pathogen entry [3–5]. Rafts have recently been detected in other
eukaryotes as well as animals, e.g. yeast [6], and plants [7]. In
these organisms, membrane cholesterol (Chol) is replaced by, or
abundantly supplemented with, other membrane-active sterols
such as ergosterol, campesterol, β-sitosterol and stigmasterol.
Lipid rafts serve as attachment sites for several cytolytic
proteins, and recently some fluorescently labelled and chemically
modified mutants of these cytolysins have been proposed as
possible selective markers for rafts. These proteins appear not only
to recognize the single lipid component that is enriched in rafts, but
also to specifically sense its distribution in the membrane. The best
Fig. 1. Chemical structure of the natural sterols and cholesterol derivatives studied in this work.
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specifically recognizes SM-enrichedmembrane domains [8,9], and
a protease-nicked and biotinylated non-toxic derivative of
perfringolysin O (θ-toxin), that selectively binds to Chol-rich
lipid rafts [10,11]. On the other hand, lipid rafts can enhance the
membrane-permeabilizing activity of pore-forming agents by
sequestering them into non-raft lipid domains. One example is a
cytolytic peptide δ-lysin from Staphylococcus aureus, whose
exclusion from lo-domains results in concentration and aggregation
of the lysin in ld-regions, leading to rapid and effective
permeabilization of the membrane [12].
Ostreolysin (Oly) is a 15 kDa acidic protein isolated from
fruiting bodies of the edible mushroom Pleurotus ostreatus [13].
This protein, belonging to the aegerolysin family [14], is speci-
fically expressed during the formation of primordia and young
fruit bodies [13,15], and is lytic to a variety of erythrocytes and
nucleated mammalian cells at sub-micromolar concentrations
[16,17]. Cell lysis is induced by a colloid-osmotic mechanism,
and the estimated radius of the Oly-induced pore is ∼2 nm [16].
Our previous study on its binding and pore-forming properties
revealed its high affinity for the Chol-rich membrane phase,
whose integrity could be disrupted by the addition of mono- and
di-unsaturated glycerophospholipids and which was tentatively
identified as a lo-phase. Further, after applying it to rodent cell
lines and to SM/Chol (1/1) vesicles, Oly was found exclusively in
detergent-resistant membranes (DRMs) [17]. These membrane
fractions have been proposed as to be lipid raft equivalents.
However, recent experimental data revealed that DRMs should
not be identified with the rafts, as they may be detergent-induced
artifactual structures [2].In contrast to lysenin or perfringolysin O, pure SM or Chol
cannot inhibit the lytic activity of Oly. Its interaction with
artificial lipid membranes requires a specific combination of
these two lipids, or a combination of Chol with fully saturated
phosphatidylcholine (PC). Its activity can additionally be
inhibited by different lysophospholipids, however all our at-
tempts to demonstrate direct binding of these molecules to Oly
failed ([16], unpublished data). In SM/Chol vesicles, permea-
bilization appears only above 30 mol% Chol, the concentration
at which this sterol induces the formation of a lo-phase [18], and
markedly increases with higher membrane Chol concentrations
[17]. Oly was found to be less active on vesicles in which Chol
was replaced by ergosterol [17], although this sterol has been
reported to induce the formation of ordered membrane domains
even more efficiently than Chol [19].
In this work, we have studied the effect of the structure of
membrane sterols and cholesterol derivatives on ostreolysin
binding and permeabilization activity. It is known that both the
sterol structure, and the structure of the adjacent phospholipids
result in different effects on membrane ordering [19–22]. Based
on our previous results [17], one would expect that ostreolysin
interaction with lipid membranes will correlate with the sterol lo-
phase-forming ability. We have assayed binding of the protein to
supported lipid monolayers and bilayers, and its lytic activity on
bilayers composed of 1/1 molar mixtures of SM with different
synthetic steroids (cholesteryl acetate, 5-cholesten-3-one), and
natural sterols (cholesterol, ergosterol,β-sitosterol, stigmasterol,
lanosterol, 7-dehydrocholesterol). We found that presence of the
free sterol 3β-OH group is an essential requirement for the
binding of Oly to supported lipid monolayers and lipid vesicles.
1664 K. Rebolj et al. / Biochimica et Biophysica Acta 1758 (2006) 1662–1670The binding and vesicle permeabilizing activity is modulated by
the number of double bonds, methylation of the steroid skeleton,
and structure of the sterol alkyl chain. Although some of the
tested sterols, e.g. ergosterol or 7-dehydrocholesterol, were
found to induce higher ordering effects over cholesterol, maxi-
mal binding and permeabilization rates were always obtained
with cholesterol-containing vesicles.
2. Materials and methods
2.1. Materials
Oly was purified from fresh young fruit bodies of Pleurotus ostreatus
according to Berne et al. [13], and frozen in aliquots at −20 °C. Before use, the
protein was diluted in 140 mM NaCl, 20 mM Tris–HCl, 1 mM EDTA, pH 8.0
(vesicle buffer).
Porcine brain sphingomyelin (SM) and wool grease cholesterol (Chol) were
from Avanti Polar Lipids (Alabaster, USA), β-sitosterol (Sito), lanosterol
(Lano), stigmasterol (Stigma), ergosterol (Ergo), 7-dehydrocholesterol (7-DHC)
were from Sigma (St. Louis, USA), and cholesteryl acetate (Ch-Ac) and 5-
cholesten-3-one (Ch-one) were from Fluka (Buchs, Switzerland) and Aldrich
(St. Louis, USA), respectively. The structure of the chosen sterols and Chol
derivatives is shown in Fig. 1. All lipids were dissolved in chloroform or other
organic solvents according to manufacturer's instructions.
1,6-diphenyl-1,3,5-hexatriene (DPH) was from Aldrich Chem. Co. (Mil-
waukee, USA), and Triton X-100 and calcein were from Sigma. All chemicals
were of the highest grade available.
2.2. Preparation of sonicated vesicles (SV)
Lipid films were formed by removing the organic solvent from a lipid
solution by rotary evaporation and vacuum drying. Lipids, at a final
concentration 10 mg/mL, were swollen in vesicle buffer or in 80 mM calcein
and vortexed vigorously to give multilamellar vesicles (MLV), that were further
sonicated as described [16]. After a centrifugation (20min, 16,000×g, 25 °C), the
vesicles were incubated for 45 min at 45 °C. In the case of calcein-containing
vesicles, extra-vesicular calcein was removed by a gel filtration on a SephadexG-
50 column. Dimensions of SV were estimated by photon correlation
spectroscopy on a Zeta Sizer instrument (Malvern Instruments, Worcestershire,
UK) as reported [17].
2.3. Characterization of the phase state of SV by differential scanning
calorimetry (DSC)
The phase transitions of equimolar mixtures of SMwith the tested steroids, and
of SM alone, were monitored using a Nano DSC series III (Calorimetry Science,Table 1
DPH fluorescence anisotropy of sonicated sphingomyelin and sphingomyelin/
steroid (1/1 molar ratio) vesicles in 140 mM NaCl, 20 mM Tris–HCl, 1 mM
EDTA, pH 8.0. Anisotropy was measured at 410 nm and 25 °C or 50 °C a
Steroid Anisotropy
None 25 °C 0.350±0.003
None 50 °C 0.150±0.002
Chol 0.330±0.004
Ch-one 0.303±0.003
Ergo 0.342±0.006
7-DHC 0.339±0.004
Sito 0.339±0.003
Stigma 0.341±0.002
a Average values and standard deviation of three independent measurements
are shown.Provo, UT, USA). Sonicated lipid vesicles (0.5 mg/mL) in vesicle buffer were
loaded into the calorimetric cell, and each sample was heated/cooled repeatedly in
the temperature range at 0 to 70 °C. The heating/cooling rate was 1 °C/min.
2.4. Anisotropy measurements
Fluorescence anisotropy measurements were performed in a 10 mm path-
length cuvette using Cary Eclipse Fluorescence Spectrophotometer (Varian,
Mulgrave, Victoria, Australia) at 25 °C, and using Varian Auto Polarizers with
slit widths with a nominal band-pass of 5 nm for both excitation and emission.
1,6-diphenyl-1,3,5-hexatriene (DPH) was added to the 100 μM solution of SV
made of pure SM, or of SM/steroid in a 1/1 molar ratio in vesicle buffer. The final
concentration of DPH was 0.5 μM. The mixture was sonicated as previously
described [16], and DPH fluorescence anisotropy was measured at an excitation
wavelength of 358 nm with the excitation polarizer oriented in the vertical
position, while vertical and horizontal components of polarized emission light
were recorded through a monocromator at 410 nm. The anisotropy was
calculated using the instrument build-in software. The value of G-factor (the ratio
of the sensitivities of the detection system for vertically and horizontally
polarized light) was determined for each sample separately.
2.5. Inhibition of ostreolysin-induced hemolysis
Binding of Oly to SV with different lipid compositions (SM/steroid in a 1/1
molar ratio) was estimated by measuring the residual hemolytic activity of
unbound Oly, using a kinetic microplate reader (MRX, Dynex Technologies,
Denkendorf, Germany). Typically, 75 μL of SVat various lipid concentrations in
vesicle buffer were pipetted onto a multiwell-plate. 25 μL of Oly (4 μg/mL) were
then added and the plate incubated for 30 min at 25 °C to allow binding of Oly to
SV. Hemolysis was then assayed by adding 100 μL of bovine erythrocyte
suspension in vesicle buffer. The decrease in turbidity at 630 nmwas recorded for
30 min to determine the time necessary for 50% hemolysis (t0.5). The lysing
mixture had an initial turbidity of 0.5 at 630 nm. The inhibitory effect of SV was
expressed as IC50, i.e. the concentration of SV that decreased the rate of
hemolysis by 50% [16].
2.6. Surface plasmon resonance (SPR) measurements of ostreolysin
binding to supported lipid monolayers
Binding of Oly to supported lipid monolayers was determined using a Biacore
X SPR apparatus and an HPA Sensor Chip (Biacore AB, Uppsala, Sweden), pre-
coated with long alkylthioether chains that form a flat, quasi-crystalline hydro-
phobic layer, and immobilize liposomes via surface interaction. In this way, the
hybrid bilayer membrane, in which alkanethiols became part of the membrane
bilayer, is formed. Such a system is a well-defined model for studying the surface
adsorption step of pore-forming proteins [23,24]. All ligands and washing chemi-
cals were prepared in the degassed vesicle buffer (140 mM NaCl, 20 mM Tris–
HCl, 1 mM EDTA, pH 8.0), which was also used as running buffer. The desired
lipidmonolayerwas coupled to the chip using SV. The SV suspensionwith 0.5mM
lipid concentration, prepared from pure SM or from SM combined with a steroid,
was injected over the chip at a flow rate of 2 μL/min to reach typically 1500±100
resonance units (RU) of deposited lipids. Loosely adsorbed lipid materials were
washed out successively with 20 μL of 100 mMNaOH (100 μL/min) and running
buffer. The supported monolayer was treated with 100 μL of 0.1 mg/mL bovine
serum albumin (20 μL/min) to minimize nonspecific binding of Oly to the micro-
fluidic system. Oly, at 5, 10, 20, 40 or 55 μM, was injected over the prepared
monolayer for 10 min, followed by injection of running buffer, to obtain dis-
sociation kinetics. At a flow rate of 10 μL/min, sensorgrams were recorded at
25 °C. After the dissociation phase following the injection of each Oly con-
centration, the protein was removed from the monolayer surface with 20 μL of
100 mM NaOH (100 μL/min). The surface was again treated with 100 μL of
0.1mg/mLbovine serumalbumin (20μL/min), and newOly injectionwas applied.
At the end of experiments, the chip surface was purged with 100 μL of 40 mM
octylglucoside in water (20 μL/min), and a new lipid monolayer was applied
following the above procedure. Bulk controls were run on monolayers with vesicle
buffer alone. Sensorgrams were processed and evaluated using BIAevaluation
Version 3.2 software (Biacore AB, Uppsala, Sweden).
Table 2
Lipid composition of sonicated vesicles, dimensions, and inhibition of
ostreolysin-induced hemolysis
Composition (1/1 molar ratio) Diameter (nm) IC50 (mg/mL)
SM/Chol 91±1 1.0
SM/7-DHC 138±12 1.3
SM/Ergo 110±2 1.6
SM/Sito 137±15 1.2
SM/Stigma 125 1.7
SM/Lano 99 2.3
SM/Ch-Ac 110 >>10
SM/Ch-one 141 >>10
IC50 denotes the concentration of SVat which the rate of hemolysis is decreased
by 50% (see Materials and methods).
Fig. 2. Sensorgrams of ostreolysin interaction with cholesterol/sphingomyelin
supported monolayers. 55 μM Oly in 140 mM NaCl, 20 mM Tris–HCl, 1 mM
EDTA, pH 8.0, was injected at 10 μl/min for 600 s over Chol/SM monolayers
coupled to a Sensor Chip HPA at 25 °C. In monolayer, Chol content was varied
from 0 to 60mol% as indicated by numbers. (A) Primary sensorgrams (solid line)
and best fits (dotted line). Total response (RU) corresponds to the response of
bound Oly together with the apparent response caused by the refractive index of
the bulk. (B) Corrected sensorgrams (solid line) and their best fits (dotted line)
were obtained by subtracting the fitted bulk component response from the
primary sensorgram. Inset, the relationship between calculatedmaximal response
without bulk response, RUmax, and Chol content in the Chol/SM monolayers.
RUmax corresponds to the theoretical number of lipid binding sites as calculated
from best fits of the two-step reaction kinetic model using the BIAevaluation 3.2
program. The SPR experiments were run in duplicate or triplicate.
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Possible aggregation of equimolar Chol/SM SV (14 μg/mL) after addition of
Oly in the final concentration of 0, 0.1, 0.5, 1, and 2 μMwas followed as an increase
in light scattering at 25 °C with a Jasco FP-750 spectrofluorometer (Jasco Ltd.,
Essex, UK). The apparatus was equippedwith awater thermostated cell holder using
1 cm path length, magnetically stirred (830 rpm) quartz cuvette. Slit widths with a
nominal band-pass of 5 nm were used for both excitation and emission, which were
both set to 400 nm.
2.8. Permeabilization of SV
Vesicle permeabilization was determined using a fluorescence microplate
reader (Tecan Genios, Grödig/Salzburg, Austria) with excitation and emission at
485 nm and 535 nm. 100 μL of Oly at various concentrations in vesicle buffer
were dispensed in a multiwell microplate, followed by an appropriate amount of
calcein-loaded SV or MLV composed of SM and steroids in a 1/1 molar ratio.
Release of calcein was then recorded for 1 h at 25 °C. Maximal (100%) calcein
release was obtained by solubilization of SV with Triton X-100, 1 mM final
concentration, and the percentage of calcein release was calculated for each well
[25]. The maximal reaction rate was defined as the maximal slope of the
permeabilization kinetics.
3. Results
3.1. Characterization of the phase state of SV by DSC and
anisotropy measurements
By applying DSC measurements, we followed the lipid
thermotropic phase behaviour of SM and SM/steroid (1/1 molar
ratio) vesicles. Porcine brain SM undergoes clear phase
transition at 37 °C from the solid state to the liquid-disordered
state. 1/1 (mol/mol) mixtures of SM with tested steroids do not
show any phase transitions. In the temperature range from 0 to
70 °C, all the lipid mixtures, even those containing Ch-on or
Ch-Ac, showed very broadened thermograms, suggesting
coexistence of several lipid phases as expected for the high
content of sterols (data not shown). Therefore, the steady-state
DPH anisotropy measurements were additionally performed to
compare the level of order in some of the tested lipid mixtures.
Anisotropy values are the highest in the gel state, lowest in the
liquid-disordered state, and intermediate in the liquid-ordered
state [22]. Results of anisotropy measurements of DPH added to
equimolar mixtures of SM with different steroids at 25 °C are
listed in Table 1. Anisotropy values of DPH in pure SM before
(at 25 °C) and after (50 °C) gel-liquid phase transition areshown for comparison. The highest value of DPH anisotropy
was observed for SM in the gel state while the lowest for the SM
in liquid state. The anisotropy values of DPH in different
equimolar SM/steroid mixtures are decreasing in the order:
Ergo≥Stigma>7-DHC≥Sito>Chol>>Ch-one.
3.2. Ostreolysin binding to steroid/SM (1/1) SV
Inhibition of Oly-induced hemolysis [16] was measured as an
indirect assessment of the binding affinity of Oly to steroid-
containing lipid vesicles. Chol-containing vesicles were the
most effective in inhibiting hemolysis (IC50=1 mg/mL), fol-
lowed by other sterol/SM mixtures in the order: Sito>7-
DHC>Ergo>Stigma>Lano (Table 2). Up to a lipid concentra-
tion of 10 mg/mL, vesicles containing Ch-one and Ch-Ac
showed no inhibition of Oly-induced hemolysis.
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monolayers
Sensorgrams, without corrections for bulk effects (primary
sensorgrams), display the association–dissociation kinetics of
Oly interaction with supported monolayers made of either pure
SM, Chol/SM at various ratios, or SM/steroid (1/1) mixtures
(Figs. 2A, 3A, 4A). In all kinetic evaluations, primary sensor-
grams were used for fitting to theoretical curves. Injection of the
buffer control revealed that, at the flow rate of 10 μL/min, there
was a delay in maximal RU response of 4.5 s following both
sample and buffer injection. In evaluating sensorgrams, we
therefore assumed that rapid changes in RU at the very
beginning of association and dissociation should be ascribed to
changes of refractive index, due to bulk effects, and not to
protein adsorption to or dissociation from the supported
monolayer. Using numerical integration analysis [26], primary
sensorgrams were fitted to a two-state reaction model, the
second step being a conformational change without an increaseFig. 3. Sensorgrams of ostreolysin interaction with cholesterol/sphingomyelin
(1/1 molar ratio) supported monolayers. Primary sensorgrams (A) and
sensorgrams after subtraction of the calculated component corresponding to
the bulk response (B) are shown. Ostreolysin concentration (μM) is indicated by
numbers. Solid line, experimental curves; dotted line, best fits. All other
conditions are the same as in Fig. 2. Inset, relationship between calculated
response without the bulk response at t=1400 s, RU1400s, and concentration of
Oly. The SPR experiments were run in duplicate or triplicate.in RU. The choice of this model is supported by the
experimental evidence that a compact native-like conformation
of Oly, and a subtle local conformational change are both
characteristic of the protein binding to the lipid membrane [14].
In the model, we assume that the binding, observed as an
increase in RU, reflects both protein adsorbtion and possible
insertion in the supported monolayer. This model, which has
been successively applied to describe the interaction of some
other proteins with lipid bilayers [27,28], is depicted by the
scheme:
Olyþ L X
kd;2
ka;2
OlyL X
kd;2
ka;2
*OlyL;
where Oly is ostreolysin, L is lipid, the asterisk designates
Oly with changed conformation, and ka,1, ka,2, kd,1, and kd,2
are association and dissociation rate constants. When fitting
single sensorgrams, goodness of the fits was characterized by
values of the χ2 test ranging from 0.2 to 3; however, global
fitting gave values over 10. It is considered that global fits
with χ2 values over 10 are not satisfactory [29], and
therefore, we do not report the calculated kinetic and equili-
brium constants.
The association–dissociation kinetics of Oly interaction
with supported monolayers made of either pure SM or Chol/
SM with increasing Chol contents, are shown by sensorgrams
(Fig. 2A). Derived sensorgrams (after subtraction of the
calculated bulk response) and best fits of the association–
dissociation component are shown in Fig. 2B. Spikes at the
start and end of the sample injection result from mismatches
between the real-time changes of the bulk response, which
exhibit a 4 to 5 s delay, and the calculated theoretical bulk
response, which is a rectangular pulse. We also observed that,
despite the use of rather high protein concentrations, no binding
equilibria could be obtained. In good agreement with previous
permeabilization results [17], SPR experiments confirmed that
(i) Oly does not bind to pure SM and that inclusion of Chol
above 30 mol% is a prerequisite, and (ii) the theoretical max-
imum number of the lipid binding sites increases in a highly
cooperative manner (Fig. 2B, inset). In contrast, a concentra-
tion-dependent linear relationship is observed for the binding of
Oly (up to 55 μM) to a SM/Chol (1/1) supported monolayer
(Fig. 3). Sensorgrams showing the interaction of 20 μM Oly
with supported monolayers made of steroid/SM (1/1) showed
again that Chol-containing mixtures were the most susceptible
for binding (Fig. 4). Dissociation of Oly from the Chol-
containing monolayer was negligible, reflecting close to
irreversible binding. Binding to lipid monolayers containing
other natural sterols was considerably lower. A rather high
extent of binding was observed with monolayers containing
Stigma, however, almost 50% of the signal was lost during the
dissociation step, suggesting a loose interaction with Oly. In
contrast, most of the signal persisted after the dissociation step
with Ergo-, Sito and 7-DHC-containing monolayers. Binding
to monolayers containing Lano or one of the synthetic Chol
derivatives was poor and comparable to binding to a pure SM-
monolayer.
Fig. 4. Sensorgrams of ostreolysin (20 μM) interaction with supported monolayers of various steroids combined with SM in a 1/1 molar ratio. (A) Primary sensorgrams
(solid line) and best fits (dotted line). (B) Corrected sensorgrams after subtraction of calculated component corresponding to bulk response. The experimental
conditions are as described in Fig. 2. The SPR experiments were run in duplicate or triplicate.
Fig. 5. Permeabilization by Oly of sonicated sphingomyelin/steroid (1/1 molar
ratio) lipid vesicles. (A) Time course of permeabilization of calcein-loaded SM/
steroid SV (20 μg/mL) treated with 6.7 μM Oly. (B) Percentage of calcein
release and (C) the maximal rate of permeabilization of SM/steroid (1/1) SV
treated with 0.067–6.7 μM Oly. (D) Relationship between RU1400, calculated
response without the bulk response at t=1400 s (see Fig. 4), and maximal rate of
calcein release from SM/steroid SV. The vesicles were composed of a 1/1 (mol/
mol) ratio of SM and Chol (●), Sito (□), 7-DHC (▾), Stigma (▵), Ergo (▪),
Lano (○), Ch-Ac (♦), and Ch-one (⋄).
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Since we did not observe any increase in light scattering in
vesicle aggregation assay (not shown) we concluded that calcein
release fromSVis a reliable assay for membrane permeabilization
by Oly. The characteristics of permeabilization of steroid/SM
vesicles (Fig. 5) byOly correlatedwell with the data on its binding
to supported monolayers (Fig. 4) and SV (Table 2). Examples of
time courses of calcein release from vesicles supplemented with
various steroids are presented in Fig. 5A. The relationship
between maximum calcein release from the various vesicles and
the concentration of Oly (Fig. 5B) shows that Chol-containing
membranes are the most susceptible to Oly-induced lysis, fol-
lowed by those enriched with Sito and 7-DHC. With these three
kinds of vesicles, 50% calcein release occurred between 0.5 and
5 μM Oly. Additionally, 2.7 μM Oly caused 75% per-
meabilization of SM/Chol (1/1) SV, while it was able to release
only 47% of calcein fromMLVwith the same composition, added
in the same protein/lipid molar ratio (not shown). This indicates
that the mechanism of permeabilization does not arise from
detergent effect, by likely from binding of the protein to the outer
lipid leaflet of MLV and subsequent formation of the pore,
suggesting that the pore-forming mechanism is responsible for
both permeabilization of cells [16] and lipid vesicles. Ergo-,
Stigma- and Lano-containing vesicles were considerably less
sensitive, and those containing either Ch-one or Ch-Ac could not
be permeabilized by Oly at all. The overall susceptibility of
steroid/SM (1/1) vesicles to Oly-induced lysis was as follows:
Chol>Sito>7-DHC>Ergo>Stigma>Lano>Ch-one=Ch-Ac.
Although the maximal permeabilization of Sito-containing
vesicles approaches that of vesicles containing Chol, the shape
of the kinetic curves at the beginning of the reaction (Fig. 5A), as
well as the maximum permeabilization rates (Fig. 5C), show that
calcein release is considerably faster in the presence of Chol.
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4.1. Cholesterol-dependence of ostreolysin resembles that of
bacterial cholesterol-dependent cytolysins
Recent results suggest that the global membrane structure, in
particular its domain organization, has considerable implications
for the susceptibility to different cytolytic proteins, especially
those whose membrane activity depends basically on the
presence of Chol. For more than 20 years, this sterol was
believed to be the receptor for a large group of highly similar
toxins isolated from different Gram-positive bacteria and known
as “cholesterol-dependent cytolysins” (CDCs). Recently, this
paradigm has been extensively revised. For example, only
membrane-bound Chol can induce oligomerization of listerio-
lysin [30], while another CDC, intermedialysin, interacts
exclusively with human cells [31], making it hard to believe
that Chol could be its exclusive acceptor. Although most CDCs
can bind to and oligomerize with crystalline Chol, recent
analyses suggest that the involvement of Chol in their cytolytic
activity is far more complex and even more important during the
pore formation than during the binding step [32,33]. Binding of
certain CDCs sharply increases above a threshold Chol
concentration in lipid vesicles [34], which is also true for Oly
([17], this work), suggesting furthermore that the distribution of
Chol molecules on the membrane, and the specific patterns that
are subsequently formed, could be of crucial importance for the
activity of this group of cytolysins. Another example of a Chol-
binding pore-forming toxin is Vibrio cholerae cytolysin (VCC),
whose crystal structure strongly resembles those of CDCs [35].
VCC was shown to bind pure Chol and oligomerize with it in
solution, although it preferred association with sphingolipid/
Chol complexes rather than with individual lipid molecules [36].
Compared to the bacterial toxins, (i) Oly cannot be bound to pure
Chol [13,16] but only to Chol or other sterol combined with SM
or saturated PC ([17], this work), and (ii) it appears that the role
of sterols is essential in the Oly binding step. There is conclusive
evidence that Oly, and probably other members of the
aegerolysins, could be functionally classified as CDCs, and
that bacteria are thus not exclusive producers of this class of
proteins.
4.2. Steroid structure and Oly activity
In our study, both binding and permeabilizing activity of Oly
on SM/steroid (1/1) bilayers, as well as binding to supported
lipid monolayers, proceeded in the same order, showing
maximal activities with Chol-containing vesicles, followed by
those containing Sito, 7-DHC, Ergo, Stigma, and Lano (Figs. 2–
5, Table 2). In all these experiments, Oly was found to be
ineffective on mono- and bilayers containing Ch-Ac or Ch-one,
and on those made of pure SM. Our results indicate that the
ability of a steroid to form the lo-lipid phase [19–22] mainly
correlates with increased susceptibility of the membrane for Oly
binding. In terms of domain formation, the low susceptibility of
Lano-containing vesicles to Oly binding and permeabilization is
not surprising, as there is strong evidence that this evolutionaryprecursor of Chol has very low packing abilities with other
phospholipids [22,37–39], exhibits the existence of the lo phase
only at quite low temperatures and/or high Lano concentration
[40], and shows no coexisting liquid immiscible phases over a
wide range of temperature and composition [41]. Binding of Oly
and its permeabilization activity was decreased by the presence
of sterols with an additional double bond in the alkyl chain
(Ergo, Stigma, Lano, see Fig. 1). Finally, the absence of Oly
activity on bilayers containing Ch-Ac or Ch-one correlates well
with the reduced ability of these steroids to induce domain
formation [42–44] (see also Table 1).
4.3. Cholesterol is preferred by CDCs
Our results on preference of Oly for cholesterol resemble those
obtained with CDCs, whose membrane activity is impaired on
interaction with either pure or membrane-bound steroids with
modification of the 3β-OH group and/or C17 isooctyl chain [30].
Pneumolysin, for example, showed just 50% hemolysis inhibition
with Ergo, and no inhibition at all with Lano [45], approaching the
values obtained here with Oly. Similarly, binding of VCC to
several crystalline sterols and steroids showed that this cytolysin
needs both a free 3β-OH group and an unmodified C17 isooctyl
chain for optimal oligomerization [46]. Interestingly, interaction
of VCC with lipid vesicles containing enantiomeric Chol was
negligible, suggesting a stereospecific mode of interaction [47].
The observed preferential permeabilization ([17], Fig. 5), and
binding (Figs. 2, 4) of Oly to Chol-containing membranes are
highly cooperative with respect to Chol membrane concentration,
reflecting the importance of membrane lateral distribution and
accessibility of Chol molecules for protein binding. Indeed, the
maximal rates of vesicle permeabilization correlate verywell with
maximal binding of Oly to supported lipid monolayers (Fig. 5D),
suggesting that the surface lipid organization of an SM/Chol lipid
mixture is the most favourable one for the interaction with Oly,
and furthermore, that the role of steroids is more important in the
binding step rather than in later events leading to pore-formation.
It has been argued that increasing the Chol concentration in
binary and ternary lipid mixtures leads to an increased chemical
activity coefficient of Chol, and yet its tendency to leave the
membrane [48]. Actually, there are pieces of experimental
evidence that such cholesterol clusters may exist in cholesterol-
enriched membranes [49,50]. It is thus suggestive that small
Chol clusters, arranged specifically in the plane of the mem-
brane, can serve as docking sites for Oly. Another possibility is
that such Chol clusters include SM molecules. In fact, binary
mixtures of Chol and phospholipids [51,52], or Chol and SM
[53] are thought to form complexes with more than one
stoichiometry at different membrane compositions. Such small
Chol-rich patches may be identical with lipid nano-domains
forming the lo-lipid phase, as discussed recently by London
[54].
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